Cytosorbents Aktie

Cytosorbents für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A12GDU / ISIN: US23283X2062

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
13.04.2020 16:31:09

Stock Alert: CytoSorbents Up 30% On FDA's Approval To Use CytoSorb For COVID-19

(RTTNews) - Shares of CytoSorbents Corp. (CTSO) jumped nearly 30% on Monday morning after the company said the U.S. FDA said granted Emergency Use Authorization to its blood purification system CytoSorb for use in patients with COVID-19 infection.

CTSO is currently trading at $8.45, up $1.86 or 28.30%, on the Nasdaq.

Under the approval, CytoSorbents can sell CytoSorb to hospitals for use in patients aged 18 years or older, with confirmed COVID-19 infection, who are admitted to the ICU with respiratory failure.

CytoSorb is plug-and-play compatible with the most commonly used blood purification machines or pumps in the intensive care unit used to treat COVID-19 patients.

The FDA said that it has concluded the CytoSorb device may be effective at treating certain patients with confirmed COVID-19 by removing various pro-inflammatory cytokines from their blood.

Analysen zu Cytosorbents Corpmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Cytosorbents Corp 0,84 -3,10% Cytosorbents Corp